Floatz logo

Therapeutic Asset Ratings

17,289 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
CIS-DIAMMINEDICHLOROPLATINUM II
Head And Neck Squamous Cell Carcinoma
AkesoP3BB (71)
CIS-DIAMMINEDICHLOROPLATINUM II
Estrogen-Receptor Negative Breast Cancer
University of WashingtonP3BB (71)
Cyclophosphamide
Nodular Lymphocyte Predominant Hodgkin Lymphoma
National Cancer Institute (NCI)P3BB (71)
Cyclophosphamide
Gastroesophageal Junction Adenocarcinoma
Beijing BiotechP3BB (71)
Cyclophosphamide
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)P3BB (71)
Cyclophosphamide
Urothelial Carcinoma
Beijing BiotechP3BB (71)
Docetaxel
Breast Carcinoma
Dana-Farber Cancer InstituteP3BB (71)
DOXORUBICIN
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)P3BB (71)
DOXORUBICIN
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)P3BB (71)
DOXORUBICIN
Ovarian Transitional Cell Carcinoma
National Cancer Institute (NCI)P3BB (71)
DOXORUBICIN
Undifferentiated Ovarian Carcinoma
National Cancer Institute (NCI)P3BB (71)
ETOPOSIDE
High Grade B-Cell Lymphoma
University of WashingtonP3BB (71)
ETOPOSIDE
Follicular Lymphoma
David Bond, MDP3BB (71)
Fenofibrate
Primary Biliary Cholangitis
Xijing Hospital of Digestive DiseasesP3BB (71)
Fludarabine
Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Translocation
Rutgers, The State University of New JerseyP3BB (71)
Fludarabine
Juvenile Myelomonocytic Leukemia
Children's Oncology GroupP3BB (71)
Fludarabine
Myelodysplastic Syndrome With Single Lineage Dysplasia
Fred Hutchinson Cancer CenterP3BB (71)
Fludarabine
Myelodysplastic Syndrome With Excess Blasts
Fred Hutchinson Cancer CenterP3BB (71)
Idarubicin
Acute Myeloid Leukemia By FAB Classification
University of NebraskaP3BB (71)
Irinotecan
Malignant Pancreatic Neoplasm
Jonsson Comprehensive Cancer CenterP3BB (71)
Irinotecan
Pancreatic Adenocarcinoma
Jonsson Comprehensive Cancer CenterP3BB (71)
Irinotecan
Rectal Carcinoma
SCRI Development Innovations, LLCP3BB (71)
Saroglitazar
Primary Biliary Cholangitis
Zydus Therapeutics Inc.P3BB (71)
TACROLIMUS
Disease Related To Hematopoietic Stem Cell Transplant
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)P3BB (71)
(+)-VINCRISTINE
Non-Hodgkin Lymphoma
Mwanasha Merrill, MDP3BB (71)
Showing 826 to 850 of 17,289 assets
PreviousPage 34 of 692Next